Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Timothy C. Thompson, Sanghee Park et al.|Science Signaling|2017Cited by 307
Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate CancerYaoguang Zhang, Timothy C. Thompson, Bo Liu et al.|Clinical Cancer Research|2017Cited by 108